Spanish Health Ministry Seeks Public Opinion on Tobacco Regulations

Regulations by 2FIRSTS.ai
Apr.09.2024
Spanish Health Ministry Seeks Public Opinion on Tobacco Regulations
Spanish Health Ministry seeks public input on Royal Decree draft, aiming to further tobacco regulation following nationwide smoking ban.

According to Spanish media La Voz de Galicia on April 8th, the Spanish Ministry of Health is officially seeking public opinions on a draft royal decree regarding plain packaging and the prohibition of additives in tobacco and related products. The aim is to evaluate and improve this legislative reform proposal. This is the first legislative measure taken following the implementation of the comprehensive smoking ban plan last Friday (April 5th).

 

Health Minister Monica Garcia emphasized at a social health breakfast organized by the European News Agency, "The plain packaging policy is effective, as it not only eliminates the attractiveness of tobacco packaging as advertising, but also helps to inspire people to quit smoking." Currently, many countries such as Australia, France, Norway, and Denmark have fully implemented plain packaging policies and have achieved significant results.

 

From now (April 8th) until April 23rd, all Spanish citizens, organizations and associations are free to express their opinions on this policy. The proposal will reform the Royal Decree 579/2017 that regulates various aspects of tobacco manufacturing, sales and commercialization.

 

The bill argues that "health protection" necessitates "emergency updates" to regulations in order to address issues such as the steady increase in tobacco and related product consumption and the exposure of ordinary people, especially young people, to new forms of nicotine consumption. It claims that current regulations are unable to keep up with the supply of these new products on the market, losing effectiveness in combining health warnings while maintaining product appeal. More importantly, there is a regulatory gap for nicotine-free e-cigarettes and herbal smoking products.

 

Therefore, the legislation aims to introduce many improvements within existing regulations, such as implementing plain packaging and "properly categorizing emerging products" to enhance labeling and packaging.

 

Additionally, this includes banning the use of tobacco-flavored additives in tobacco and related products, as well as additives and ingredients that distort health regulations' objectives or may be more appealing to consumers.

 

This is the first initiative launched by the Spanish Ministry of Health since the release of the Comprehensive Tobacco Addiction Prevention Plan (PIT) for 2024-2027. The plan was approved last Friday (April 5th) by the entire Interregional Health Committee after being reviewed.

 

Minister of Health Monica Garcia stated:

 

I want to express my deep gratitude to all the local regions that are working towards achieving this important consensus. For those like the skeptics in 2005 who predicted the first tobacco act would have a 'doomsday' effect and ultimately failed, as well as those 'lobby groups with commercial interests,' they will hit a wall if they try to influence this department on anything related to protecting the health of our citizens.

 

In addition to other measures, some of the initiatives included in the plan will harmonize regulations on tobacco-related products with traditional tobacco regulations: The Ministry of Finance has revised tobacco taxes to bring Spain closer to its neighboring countries, with hopes that this increase in revenue can be used to advance public health policies. At the same time, it also includes expanding smoke-free zones.

 

Another goal of the program is to promote research on tobacco and its effects, strengthening evidence on the impacts of new tobacco products. The minister criticized those who were against the plan from the start, had apocalyptic ideas, and made similar statements as early as 2005 and 2010.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

NAS 2026 | Cliff Douglas: Risk Continuum Should Play a Central Role in Tobacco Policy
NAS 2026 | Cliff Douglas: Risk Continuum Should Play a Central Role in Tobacco Policy
Cliff Douglas, a veteran U.S. tobacco-control and public health policy figure, told NAS 2026 that the “continuum of risk” should play a central role in tobacco policy. He called for clearer market pathways, stronger risk communication, differentiated regulation and enforcement, and said possible FDA reforms to PMTA reviews could be a “welcome correction” if they create a more efficient, predictable route for scientifically substantiated lower-risk products. Read 2Firsts’ on-site coverage.
Sep.26
2Firsts First Look|China to End VAT Export Rebates on Vape Devices and Nicotine in April 2027, Following Earlier Removal for HTP Devices and Nicotine Vapes
2Firsts First Look|China to End VAT Export Rebates on Vape Devices and Nicotine in April 2027, Following Earlier Removal for HTP Devices and Nicotine Vapes
China's Ministry of Finance and State Taxation Administration announced on October 12, 2026, that value-added tax (VAT) export rebates for vape devices, nicotine and its salts, and certain non-combustible inhalation products will be eliminated from April 1, 2027. The measure adds four tobacco- and nicotine-related customs codes, including 8543400010, which covers vape devices and qualifying empty pods. China previously eliminated rebates for nicotine-containing vaping products and devices under code 8543400090 in April 2026. According to industry classification information held by 2Firsts, the latter currently corresponds to heated tobacco devices. Export excise tax refund and exemption arrangements will remain unchanged.
Special Report
Oct.12
Philippines Mandates Safety Certification for Nicotine Pouches, Gives Industry 12 Months to Comply
Philippines Mandates Safety Certification for Nicotine Pouches, Gives Industry 12 Months to Comply
The Philippines Department of Trade and Industry has placed nicotine pouches under mandatory product certification through Department Administrative Order No. 26-07, Series of 2026. Nicotine pouches must obtain a Philippine Standard, or PS, license before they can be manufactured, imported, packed, distributed or sold in the country. The regime requires testing for nicotine content, pH and water activity, while packaging must disclose nicotine strength, ingredients, allergens, batch information, the PS certification mark and prescribed health warnings. Existing market participants have a 12-month transition period to comply.
Regulations
Oct.12
India Steps Up Nicotine Pouch Enforcement as ZYN, White Fox Circulate and Drug Panel Urges Halt to New Nicotine Formulations
India Steps Up Nicotine Pouch Enforcement as ZYN, White Fox Circulate and Drug Panel Urges Halt to New Nicotine Formulations
India's Ministry of Health and Family Welfare has directed states to step up enforcement against nicotine pouch sales, citing increased availability through online and offline channels and concern about nicotine exposure among children. Reuters reported that international brands including ZYN and White Fox are being sold in India. A study led by ICMR-NICPR found pouches in seven of 10 surveyed locations and identified 68 brands and 445 flavors online. Separately, India's Drugs Technical Advisory Board recommended in August that no new nicotine formulation be approved.
Regulations
Sep.28 by 2Firsts Perspectives
AIR Q3 Sales Rise 11%, but New Products Generate Just $2.1 Million in Nine Months as U.S. Vape Push Awaits FDA Review
AIR Q3 Sales Rise 11%, but New Products Generate Just $2.1 Million in Nine Months as U.S. Vape Push Awaits FDA Review
AIR Global PLC (NASDAQ: AIIR), a producer of flavored shisha tobacco and next-generation nicotine products, reported an 11.1% increase in third-quarter 2026 revenue to $99.8 million and a 7.7% rise in adjusted EBITDA to $30.9 million. Revenue for the first nine months increased 6.0% to $306.7 million, but the company posted a $74.2 million net loss, affected by listing-related expenses and other costs. Its New Growth Categories (NGC) business generated $2.1 million in nine-month revenue and an adjusted EBITDA loss of $10.8 million. AIR maintained its 2026 revenue growth guidance of 4%–6%, while lowering its capital expenditure outlook and raising its year-end leverage forecast from approximately 2.1 times to 2.5 times. The company has submitted a U.S. PMTA for its Crown Switch pod vape, with future contributions from new products dependent on regulatory progress and commercialization.
Capital Markets
Nov.13
Why AIRSCREAM Built its European Production Hub for Regulated Market Growth
Why AIRSCREAM Built its European Production Hub for Regulated Market Growth
AIRSCREAM’s production hub in the Czech Republic brings nicotine pouch manufacturing, e-liquid bottling, product documentation, warehousing and international logistics into one operation, giving brands and commercial partners a practical platform from which to launch, expand and enter new markets.
Market
Sep.16 by 2Firsts Perspectives